IONIS PHARMACEUTICALS INC cotiza a 43.74 USD y tiene una capitalización bursátil de $7.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary a…
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.42 | $-0.30 | $-1.15 |
| Estimado | $-0.92 | $-0.88 | $-0.77 | $-1.22 |
| Sorpresa | — | +52.3% | +61.0% | +5.7% |
| Métrica | IONS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 98.3% | 57.0% | +41.3% |
| Operating Margin | -40.5% | -38.6% | -1.8% |
| Net Margin | -40.4% | -33.6% | -6.8% |
| FCF Margin | -33.9% | -13.9% | -20.0% |
| ROE | -78.0% | -40.4% | -37.6% |
| ROA | -10.8% | -32.0% | +21.2% |
| Current Ratio | 3.83 | 2.84 | +0.99 |
| Debt / Equity | 3.71 | 0.28 | +3.43 |